0.5792
price down icon6.66%   -0.0413
after-market Dopo l'orario di chiusura: .55 -0.0292 -5.04%
loading
Precedente Chiudi:
$0.6205
Aprire:
$0.6187
Volume 24 ore:
385.47K
Relative Volume:
1.00
Capitalizzazione di mercato:
$19.44M
Reddito:
$3.04M
Utile/perdita netta:
$-33.97M
Rapporto P/E:
-0.4355
EPS:
-1.33
Flusso di cassa netto:
$-52.47M
1 W Prestazione:
-10.63%
1M Prestazione:
-47.82%
6M Prestazione:
-71.33%
1 anno Prestazione:
-88.42%
Intervallo 1D:
Value
$0.5748
$0.6191
Intervallo di 1 settimana:
Value
$0.5748
$0.6563
Portata 52W:
Value
$0.4619
$5.7399

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
Nome
Rani Therapeutics Holdings Inc
Name
Telefono
(408) 457-3700
Name
Indirizzo
2051 RINGWOOD AVENUE, SAN JOSE
Name
Dipendente
106
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
RANI's Discussions on Twitter

Confronta RANI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
0.5792 21.76M 3.04M -33.97M -52.47M -1.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.68 25.81B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
447.09 111.46B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 40.37M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.39 64.44B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
77.49 6.19B 0 -153.72M -103.81M -2.00

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-02 Iniziato Oppenheimer Outperform
2024-06-14 Iniziato Maxim Group Buy
2024-06-13 Iniziato Rodman & Renshaw Buy
2023-04-17 Ripresa BTIG Research Buy
2022-10-11 Iniziato UBS Buy
2022-07-27 Iniziato H.C. Wainwright Buy
2022-06-13 Iniziato Wedbush Outperform
Mostra tutto

Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie

pulisher
May 29, 2025

Rani Therapeutics announces annual meeting results - Investing.com

May 29, 2025
pulisher
May 29, 2025

Rani Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

May 29, 2025
pulisher
May 25, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $9.40 Consensus PT from Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

What is Zacks Small Cap’s Estimate for RANI Q3 Earnings? - Defense World

May 23, 2025
pulisher
May 22, 2025

Q2 Earnings Estimate for RANI Issued By Zacks Small Cap - Defense World

May 22, 2025
pulisher
May 21, 2025

Rani Therapeutics (NASDAQ:RANI) Stock Price Up 7% – Here’s What Happened - Defense World

May 21, 2025
pulisher
May 20, 2025

Rani Therapeutics Secures $4.3M via Series D Warrant - TipRanks

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics strikes deal to issue new warrants - Investing.com

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics strikes deal to issue new warrants By Investing.com - Investing.com UK

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics Announces Research Agreement with Chugai - GlobeNewswire

May 20, 2025
pulisher
May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

RANI: 1Q:25 Financial Results - MSN

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics (RANI) Partners with Chugai for Innovative Research | RANI Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs By Investing.com - Investing.com India

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics Enters Research Agreement with Chugai Pharmaceutical to Explore Oral Delivery Technology for Antibody Development - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Breakthrough: Rani's Oral Biologics Platform Matches Injectable Drugs in Chugai Partnership Study - Stock Titan

May 19, 2025
pulisher
May 18, 2025

Oppenheimer Has Lowered Expectations for Rani Therapeutics (NASDAQ:RANI) Stock Price - Defense World

May 18, 2025
pulisher
May 16, 2025

RANI Stock Update: Analyst Maintains Rating, Lowers Price Target | RANI Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Oppenheimer Adjusts Rani Therapeutics Price Target to $4 From $14, Maintains Outperform Rating - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Oppenheimer Adjusts Rani Therapeutics (RANI) Price Target | RANI Stock News - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Rani Therapeutics Highlights Promising Preclinical Data - TipRanks

May 15, 2025
pulisher
May 13, 2025

Rani Therapeutics Q1 2025 Earnings: EPS Misses at -$0.22, Revenue Surpasses Estimates at $0.2 Million - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Q1 Net Income USD -12.738 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Holdings, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Achieves Major Milestone: Oral Obesity Drug Shows Equal Success to Injections in Latest Data - Stock Titan

May 13, 2025
pulisher
May 08, 2025

Ratio Analysis: Unpacking Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 08, 2025
pulisher
May 07, 2025

Rani Therapeutics faces Nasdaq delisting over market value By Investing.com - Investing.com India

May 07, 2025
pulisher
May 06, 2025

Rani Therapeutics faces Nasdaq delisting over market value - Investing.com

May 06, 2025
pulisher
May 06, 2025

Rani Therapeutics Faces Nasdaq Compliance Challenge - TipRanks

May 06, 2025
pulisher
May 05, 2025

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - ADVFN

May 05, 2025
pulisher
May 03, 2025

Rani Therapeutics (RANI) Expected to Announce Quarterly Earnings on Monday - Defense World

May 03, 2025
pulisher
Apr 30, 2025

Rani Therapeutics Board Restructures After DeBuono’s Retirement - TipRanks

Apr 30, 2025
pulisher
Apr 28, 2025

Ratio Examination: Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Daily Progress: XPLR Infrastructure LP (XIFR) Drop -1.51, Closing at 8.46 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Recap: PowerFleet Inc (AIOT)’s Negative Momentum, Closing at 5.12 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Highlights: Clear Channel Outdoor Holdings Inc (CCO) Ends on a Low Note at 1.02 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Post-Trade Analysis: Baytex Energy Corp (BTE) Climbs 0.61, Closing at 1.65 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World

Apr 27, 2025
pulisher
Apr 16, 2025

SEC Form DEFA14A filed by Rani Therapeutics Holdings Inc. - Quantisnow

Apr 16, 2025
pulisher
Apr 05, 2025

HC Wainwright Reaffirms “Buy” Rating for Rani Therapeutics (NASDAQ:RANI) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

What is Zacks Small Cap’s Forecast for RANI FY2025 Earnings? - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

Rani Therapeutics stock hits 52-week low at $1.24 - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.33 Consensus PT from Analysts - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

BTIG maintains Buy on Rani Therapeutics stock, $14 target - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

RANI: 2024 Financial Results - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Stifel maintains Buy on Rani Therapeutics, $8 target By Investing.com - Investing.com South Africa

Apr 01, 2025

Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.06
price up icon 0.95%
$31.31
price up icon 3.40%
$580.95
price up icon 0.82%
$292.90
price up icon 2.57%
$4.64
price up icon 6.67%
$77.49
price up icon 4.82%
Capitalizzazione:     |  Volume (24 ore):